Nomura Asset Management’s Relay Therapeutics RLAY Stock Holding History

Nomura Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-31,877	Closed	-$268K	–	1546
2023 Q3	$268K	Hold	31,877	–	–	﹤0.01%	888
2023 Q2	$400K	Buy	31,877 +9,262	+41%	+$115K	﹤0.01%	876
2023 Q1	$372K	Hold	22,615	–	–	﹤0.01%	882
2022 Q4	$338K	Buy	+22,615	New	+$433K	﹤0.01%	887
2022 Q2	–	Sell	-14,000	Closed	-$419K	–	1563
2022 Q1	$419K	Hold	14,000	–	–	﹤0.01%	902
2021 Q4	$430K	Buy	+14,000	New	+$442K	﹤0.01%	915
2021 Q3	–	Sell	-14,000	Closed	-$512K	–	1015
2021 Q2	$512K	Hold	14,000	–	–	﹤0.01%	907
2021 Q1	$484K	Hold	14,000	–	–	﹤0.01%	890
2020 Q4	$582K	Hold	14,000	–	–	﹤0.01%	865
2020 Q3	$596K	Buy	+14,000	New	+$534K	﹤0.01%	841

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Nomura Asset Management's RLAY Position: Q4 2023 in Review

Nomura Asset Management sold out of Relay Therapeutics (RLAY) in Q4 2023, closing a stake of 31,877 shares — an estimated $268K sold.

Nomura Asset Management first reported a position in RLAY in Q3 2020 and held it in 10 quarters. The position peaked at $596K in Q3 2020. 177 funds tracked by Wall St. Rank hold RLAY as of Q4 2023.

Nomura Asset Management reported no remaining Relay Therapeutics position as of Q4 2023 after selling out during the quarter.
Nomura Asset Management sold 31,877 Relay Therapeutics shares in Q4 2023, an estimated $268K.
Nomura Asset Management first reported a position in Relay Therapeutics in Q3 2020 and held it in 10 quarters.
Nomura Asset Management's Relay Therapeutics position peaked at $596K in Q3 2020.
177 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2023.

Based on Nomura Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.